GlaxoSmithKline Consumer Healthcare marked the 10th anniversary of when therapeutic nicotine products became available over-the-counter at the 13th World Conference on Tobacco OR Health.
The firm said that its therapeutic nicotine products have helped more than five million smokers around the world successfully quit using safe and effective stop-smoking aids. Yet, it added, there is a significant need to encourage and educate the more than 1.3 billion smokers around the world on how to quit successfully. Shifts in public policy, like smoke-free laws and cigarette tax increases, are encouraging more and more smokers to attempt quitting. It is important that those smokers have access to counselling, behavioral support programs, and safe and effective stop-smoking products. At the conference, GSK highlighted the latest support resources available to smokers.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze